TrialEuropean journal of clinical pharmacology2018

Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers.

P Uusalo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.